| 1/14/2021 |
Canadian Market Remains In Positive Territory After Steady Start |
Business Insider |
... for the quarter ended November 2020, compared to a loss in the year-ago quarter.Aurora Cannabis (ACB.TO) is surging up 8%, Cronos Group (CRON.TO) is up 6/8%, Aurinia Pharmaceuticals (AUP.TO) is gaining 4.5%, Canopy Growth Corporation (WEED.TO) is advancing 3.75% and Trillium Therapeutics (TRIL.TO) is up 2.7%.Among the gainers in the energy section, Crescent Point Energy (CPG.TO) is up 7.3%, Husky Energy (HSE.TO) is gaining 5.2% and Cenovus ... |
| 1/11/2021 |
Cannabis Stocks Watchlist: Marijuana Deal Falls Apart - TheStreet |
TheStreet |
See how cannabis stocks such as Tilray, Cronos Group, GW Pharma and Canopy Growth performed in the market this week." link rel="preconnect" href ... |
| 1/10/2021 |
Aphria (NASDAQ:APHA) versus Canopy Growth (NASDAQ:CGC) Head-To-Head Contrast |
Daily Political |
Aphria ( NASDAQ:APHA ) and Canopy Growth ( NASDAQ:CGC ) are both medical business? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk. Aphria and Canopy Growth’s Earnings and Valuation This table compares Aphria and Canopy Growth’s gross revenue, earnings per share and valuation.Aphria has higher revenue and earnings than Canopy Growth. Aphria is trading at a ... |
| 1/10/2021 |
Reviewing Aphria (NASDAQ:APHA) and Canopy Growth (NASDAQ:CGC) |
zolmax.com |
Aphria beats Canopy Growth on 10 of the 15 factors compared between the two stocks.Aphria Company ProfileAphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through ... |
| 1/10/2021 |
The 10 Largest Marijuana Stocks in 2021 | The Motley Fool |
fool.com |
... retail sale.This burgeoning industry has given rise to 10 marijuana stocks with at least a $2 billion valuation. Here's how these industry titans rank as we enter 2021. Image source: Getty Images. 1. Canopy Growth : $9.18 billionAs has been the case for years, Canadian licensed producer Canopy Growth ( NASDAQ:CGC ) is the largest pot stock in the world -- although it's lost its large-cap status. Canopy's mammoth cash ... |
| 1/7/2021 |
Extreme Option Profits Chart of Day…Canopy Growth (CGC) |
tradingconceptsinc.com |
... serve as health and human services secretary, who reportedly supports legalization, too. That coupled with broader support for legalization, according to polls, could be incredibly bullish for related stocks.For example, cannabis stocks, like Canopy Growth (CGC) could run to higher highs on the news.The opportunities we find quite often inside Extr eme Option Profits. EARN 58% & MORE Per Trade On Average & Risk 91% LESS Doing It!Potentially EARN ... |
| 1/4/2021 |
Canopy Growth sues GW Pharma • Trinidad delays cannabis report • USVI awards first hemp license • & more… |
cannabiswire.com |
January 4, 2021 Canopy Growth sues GW Pharma • Trinidad delays cannabis report • USVI awards first hemp license • & more…The Cannabis Wire Daily newsletter is sent to C-Wire Plus subscribers every weekday morning at 7 a.m. Excerpts are published here later in the day. Don’t miss the full picture. Subscribe now . Canopy Growth sues GW Pharmaceuticals.In short, Canopy Growth ’s suit focuses on “patent ... |
| 1/3/2021 |
Natural Alternatives International (NASDAQ:NAII) versus Canopy Growth (NASDAQ:CGC) Critical Comparison |
Daily Political |
Natural Alternatives International ( NASDAQ:NAII ) and Canopy Growth ( NASDAQ:CGC ) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, analyst recommendations and institutional ownership. Earnings and Valuation This table compares Natural Alternatives International and Canopy Growth’s gross revenue, earnings per share and valuation. Natural Alternatives International has higher earnings, but lower ... |
| 1/1/2021 |
Analyzing Natural Alternatives International (NASDAQ:NAII) & Canopy Growth (NASDAQ:CGC) |
baseballnewssource.com |
Natural Alternatives International has higher earnings, but lower revenue than Canopy Growth.SummaryNatural Alternatives International beats Canopy Growth on 7 of the 10 factors compared between the two stocks.About Natural Alternatives InternationalNatural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private ... |
| 12/31/2020 |
Canopy Growth Sues GW Pharma Over CO2 Extraction Patent |
ministryofhemp.com |
... technology.Canopy Growth, based in Canada, launched their lawsuit on December 22, 2020. That’s the same day the massive cannabis corporation received an expansion on a key patent , according to Marijuana Moment.The Canopy Growth lawsuit “will impact the industry for the next 100 years.” Troy Ivan, CEO of ExtractCraftThe Canopy Growth lawsuit could have lasting consequences for the hemp and cannabis industry. At issue is a ... |
| 12/30/2020 |
Financial Survey: Natural Alternatives International (NASDAQ:NAII) versus Canopy Growth (NASDAQ:CGC) |
slatersentinel.com |
Natural Alternatives International has higher earnings, but lower revenue than Canopy Growth.Insider & Institutional Ownership30.1% of Natural Alternatives International shares are owned by institutional investors. Comparatively, 8.9% of Canopy Growth shares are owned by institutional investors. 26.4% of Natural Alternatives International shares are owned by company insiders. Comparatively, 0.3% of Canopy Growth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and ... |
| 12/30/2020 |
Does 1+1=3 for This Merger Between Two Cannabis Heavyweights? |
fool.com |
... company, with Tilray shareholders holding the remaining 38%. This transaction will produce a current market capitalization for the new Tilray around $3.2 billion, placing them second among exchange traded cannabis companies after industry leader Canopy Growth ( NASDAQ:CGC ) at $9.6 billion and just ahead of Cronos Group ( NASDAQ:CRON ) at $2.6 billion. If you haven't gotten in on the action yet, is now the time? Image source: Getty Images Why ... |
| 12/28/2020 |
CBD makers using C02 extraction may be violating patent, Canopy says | Cannabis Law Report |
cannabislaw.report |
CBD makers using C02 extraction may be violating patent, Canopy saysHemp Today reports…Canadian cannabis giant Canopy Growth says CBD makers employing a specific CO2 extraction method could owe them licensing fees or compensation.Canopy made the claim in a patent infringement lawsuit filed this week against UK-based medical CBD maker GW Pharmaceuticals. The suit could have broad implications for any companies making both THC and CBD ... |
| 12/28/2020 |
Cannabidiol CO2 Extraction Patent Action Launched |
hempgazette.com |
Home News Cannabidiol CO2 Extraction Patent Action Launched Cannabidiol CO2 Extraction Patent Action Launched By - December 29, 2020Canada’s Canopy Growth is taking on the UK’s GW Pharmaceuticals over a widely used cannabidiol extraction method.The company recently filed its complaint in the US District Court for the Western District of Texas Waco Division.Canopy Growth says it acquired all right, title, and interest in the 10,870,632 Patent ... |
| 12/28/2020 |
What if Canopy Growth acquired Village Farms? |
cantechletter.com |
Filed under: All posts , Cannabis Stock: vff weed What if Canopy Growth acquired Village Farms?Consolidation continues in the burgeoning North American cannabis market and one deal that makes a lot of sense, says Raymond James analyst Rahul Sarugaser, would be a merger between Canopy Growth ( Canopy Growth TSX:WEE D) and Village Farms ( Village Farms TSX:VFF ).In a company brief to clients on December 24, Sarugaser reiterated his ... |
| 12/28/2020 |
Why You Should Own Canopy Growth in 2021 |
fool.com |
Why You Should Own Canopy Growth in 2021 This Canadian pot stock has a financially strong future. Dec 28, 2020 at 1:29PM Author Bio Sushree is a new member of the Fool family, keen on writing about the cannabis and healthcare sector and also has five years of experience writing on real estate, consumer sector, and macroeconomic topics. She holds a bachelor’s degree in business management, specializing in finance ... |
| 12/27/2020 |
Canopy Growth Sues GW Pharma for Using Their Patent |
loudcloudhealth.com |
... have any idea of how it’s all made ?Well, one of the most popular manufacturing processes — the CO2 method — uses carbon dioxide to extract the required components of the plant.However, Canopy Growth , one of the biggest cannabis producers in Canada, claims they hold the right to this technology .Namely, just recently, the company received a US patent. And now, anyone caught using their technology potentially owes ... |
| 12/24/2020 |
TSX Ends Higher Again |
vixc.com |
... respectively. Whitecap Resources (WCP.TO), Cenovus Energy (CVE.TO), Vermilion Energy (VET.TO), Seven Generations Energy (VII.TO), Imperial Oil (IMO.TO), Suncor Energy (SU.TO), Husky Energy (HSE.TO) and Parex Resources (PXT.TO) gained 4 to 6%. Among healthcare shares, Canopy Growth Corp (WEED.TO), Aurora Cannabis (ACB.TO), Aphria Inc. (APHA.TO) and Trillium Therapeutics (TRIL.TO) gained 3.5 to 4%. In the consumer discretionary section, Magna International (MG.TO) spurted 8.5% after the company announced a joint venture with ... |
| 12/24/2020 |
Cannabis firm Canopy Growth sues GW Pharma, claiming patent infringement |
mjbizdaily.com |
Cannabis firm Canopy Growth sues GW Pharma, claiming patent infringement Published December 23, 2020Canadian cannabis producer Canopy Growth Corp. is suing Britain’s GW Pharmaceuticals in U.S. federal court, alleging that GW is knowingly infringing upon Canopy’s intellectual property.GW uses a Canopy-patented method to extract the CBD that’s the active ingredient in its Epidiolex medication, according to a complaint filed Tuesday in the U.S. District ... |
| 12/24/2020 |
Global Cannabis Market Report 2020 Featuring Aphria, Aurora Cannabis, Cannabis Science, Canopy Growth, Medical Marijuana, Inc, VIVO Cannabis, Tikun Olam, Terra Tech, Tilray and The Cronos Group |
twostonedbirds.com |
No Result View All Result Global Cannabis Market Report 2020 Featuring Aphria, Aurora Cannabis, Cannabis Science, Canopy Growth, Medical Marijuana, Inc, VIVO Cannabis, Tikun Olam, Terra Tech, Tilray and The Cronos GroupDUBLIN , Dec. 18, 2020 /PRNewswire/ — The “Cannabis Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Product Type; Application; and Geography” report has been added to ResearchAndMarkets.com’s offering.Tetrahydrocannabinol-Dominant Segment to ... |